Skip to main content
. 2008 May 20;295(1):E155–E161. doi: 10.1152/ajpendo.90228.2008

Fig. 4.

Fig. 4.

Change in glycolytic rate above basal rates in response to physiological concentrations of glucagon or insulin in the absence and presence of the phosphoinositde 3-kinase (PI3K) inhibitor LY-294002 (10 μM) or the AC inhibitor NYK80 (20 μM). *Significant difference from the response generated in the absence of inhibitor (P < 0.05, n = 3–7).